» Articles » PMID: 37511213

Two "Edges" in Our Knowledge on the Functions of Ribosomal Proteins: The Revealed Contributions of Their Regions to Translation Mechanisms and the Issues of Their Extracellular Transport by Exosomes

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Jul 29
PMID 37511213
Authors
Affiliations
Soon will be listed here.
Abstract

Ribosomal proteins (RPs), the constituents of the ribosome, belong to the most abundant proteins in the cell. A highly coordinated network of interactions implicating RPs and ribosomal RNAs (rRNAs) forms the functionally competent structure of the ribosome, enabling it to perform translation, the synthesis of polypeptide chain on the messenger RNA (mRNA) template. Several RPs contact ribosomal ligands, namely, those with transfer RNAs (tRNAs), mRNA or translation factors in the course of translation, and the contribution of a number of these particular contacts to the translation process has recently been established. Many ribosomal proteins also have various extra-ribosomal functions unrelated to translation. The least-understood and -discussed functions of RPs are those related to their participation in the intercellular communication via extracellular vesicles including exosomes, etc., which often carry RPs as passengers. Recently reported data show that such a kind of communication can reprogram a receptor cell and change its phenotype, which is associated with cancer progression and metastasis. Here, we review the state-of-art ideas on the implications of specific amino acid residues of RPs in the particular stages of the translation process in higher eukaryotes and currently available data on the transport of RPs by extracellular vesicles and its biological effects.

Citing Articles

Soy Protein-Cultured Mesenchymal Stem Cell-Secreted Extracellular Vesicles Target the Neurovascular Unit: Insights from a Zebrafish Brain Injury Model.

Lin T, Hsieh P, Lin H, Chiang C, Sheu J, Chang W ACS Biomater Sci Eng. 2025; 11(3):1432-1444.

PMID: 40000145 PMC: 11897944. DOI: 10.1021/acsbiomaterials.4c02304.


The Influence of Extra-Ribosomal Functions of Eukaryotic Ribosomal Proteins on Viral Infection.

Zhao Z, Ruan S, Li Y, Qi T, Qi Y, Huang Y Biomolecules. 2025; 14(12.

PMID: 39766272 PMC: 11674327. DOI: 10.3390/biom14121565.


CRABP1-complexes in exosome secretion.

Nhieu J, Wei C, Ludwig M, Drake J, Wei L Cell Commun Signal. 2024; 22(1):381.

PMID: 39075476 PMC: 11285139. DOI: 10.1186/s12964-024-01749-w.


Functional Activity of Isoform 2 of Human eRF1.

Shuvalov A, Klishin A, Biziaev N, Shuvalova E, Alkalaeva E Int J Mol Sci. 2024; 25(14).

PMID: 39063238 PMC: 11277123. DOI: 10.3390/ijms25147997.


Multi-omics profiling reveals dysregulated ribosome biogenesis and impaired cell proliferation following knockout of CDR2L.

Tveit Solheim E, Gerking Y, Krakenes T, Herdlevaer I, Birkeland E, Totland C BMC Cancer. 2024; 24(1):645.

PMID: 38802745 PMC: 11129367. DOI: 10.1186/s12885-024-12399-z.

References
1.
Khatter H, Myasnikov A, Natchiar S, Klaholz B . Structure of the human 80S ribosome. Nature. 2015; 520(7549):640-5. DOI: 10.1038/nature14427. View

2.
Bowen A, Musalgaonkar S, Moomau C, Gulay S, Mirvis M, Dinman J . Ribosomal protein uS19 mutants reveal its role in coordinating ribosome structure and function. Translation (Austin). 2016; 3(2):e1117703. PMC: 4721500. DOI: 10.1080/21690731.2015.1117703. View

3.
Ben-Shem A, Garreau de Loubresse N, Melnikov S, Jenner L, Yusupova G, Yusupov M . The structure of the eukaryotic ribosome at 3.0 Å resolution. Science. 2011; 334(6062):1524-9. DOI: 10.1126/science.1212642. View

4.
Sun M, Xu B, Wu Q, Chen W, Cai S, Zhang H . Cisplatin-Resistant Gastric Cancer Cells Promote the Chemoresistance of Cisplatin-Sensitive Cells via the Exosomal RPS3-Mediated PI3K-Akt-Cofilin-1 Signaling Axis. Front Cell Dev Biol. 2021; 9:618899. PMC: 7905060. DOI: 10.3389/fcell.2021.618899. View

5.
Li M, Zhao C, Chen L, Yao F, Zhong F, Chen Y . Quantitative Proteomic Analysis of Plasma Exosomes to Identify the Candidate Biomarker of Imatinib Resistance in Chronic Myeloid Leukemia Patients. Front Oncol. 2022; 11:779567. PMC: 8724304. DOI: 10.3389/fonc.2021.779567. View